Fatty acid synthase inhibitors

A compound according to Formula (I):

• wherein,
• R1 is selected from the group consisting of H, CO2R4, COR4, CONR5R6, CH(OH)R4, CR4═NOR4, heteroaryl and substituted heteroaryl;
• R2 is selected from the group consisting of H, COR4, and CH(OH)R4;
• R3 is selected from the group consisting of aryl, substituted aryl, heteroaryl and substituted heteroaryl;
• R4 is H or lower alkyl;
• R5 and R6 are, independently, H, or lower alkyl or, together, form a 5 or 6 membered ring selected from the group consisting of piperidine, piperazine, pyrrolidine, morpholine and hydroxy piperidine;
• and
• n is an integer from 1 to 6;
• or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable salt complex thereof.